Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2012
10/30/2012CA2678572C Mitochondrial targeting and import of a virus to deliver a nucleic acid
10/30/2012CA2669355C Guggulphospholipid methods and compositions
10/26/2012WO2012145743A1 Microrna-140-5p as a tumor suppressor and sensitizing agent for chemotherapy
10/26/2012WO2012145729A2 Methods and compositions for modulating gene expression using components that self assemble in cells and produce rnai activity
10/26/2012WO2012145674A1 Modulation of hepatitis b virus (hbv) expression
10/26/2012WO2012145653A2 Therapeutic combinations for use in neoplasia
10/26/2012WO2012145624A2 Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
10/26/2012WO2012145601A2 Adeno-associated virus virions with variant capsid and methods of use thereof
10/26/2012WO2012145597A2 Recombinant virus products and methods for inhibition of expression of myotilin
10/26/2012WO2012145582A2 Methods and compositions for the specific inhibitions of egfr by double-stranded rna
10/26/2012WO2012145509A2 Adeno-associated-virus rep sequences, vectors, and viruses
10/26/2012WO2012145363A1 METHODS OF USING miRNA FROM BODILY FLUIDS FOR EARLY DETECTION AND MONITORING OF MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (AD)
10/26/2012WO2012144220A1 Ezh2 as target gene for cancer therapy and diagnosis
10/26/2012WO2012116357A3 Use of agr3 for treating cancer
10/26/2012WO2012097049A3 Dna repair enzyme inhibitor nanoparticles and uses thereof
10/26/2012WO2012094560A3 Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases
10/26/2012WO2012075490A3 Anti-podoplanin antibodies and methods of use
10/26/2012WO2012027462A9 Compositions and methods for treating neoplasia
10/26/2012CA2839773A1 Recombinant virus products and methods for inhibition of expression of myotilin
10/26/2012CA2833870A1 Adeno-associated virus virions with variant capsid and methods of use thereof
10/25/2012US20120272342 Mouse artificial chromosome vector
10/25/2012US20120270926 siRNA Targeting Apoliprotein (APOB)
10/25/2012US20120270925 Antisense molecules and methods for treating pathologies
10/25/2012US20120270924 Oligomeric Compounds For The Modultion of HIF-1A Expression
10/25/2012US20120270266 Nucleic ac1d and amino ac1d sequences encoding high-level expressor factor viii polypeptides and methods of use
10/25/2012US20120269863 Methods and compositions for regulating lymphocyte activity
10/25/2012US20120269861 Treatment of breast cancer with iodonitrobenzamides in combination with anti-tumor agents
10/25/2012US20120269858 Polypeptides
10/25/2012US20120269851 Expression cassettes endcoding hiv-1 south african subtype c modified proteins
10/25/2012US20120269840 Expression of hiv polypeptides and production of virus-like particles
10/25/2012US20120269835 Process for the production of immunogenic compositions
10/25/2012US20120269788 Antidotes for factor xa inhibitors and methods of using the same
10/25/2012US20120269784 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
10/25/2012US20120269773 Recombinant adenoviruses encoding the specific iodine transporter (nis)
10/24/2012EP2514827A1 CNS gene delivery using peripheral administration of AAV10 vectors
10/24/2012EP2514824A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
10/24/2012EP2514823A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
10/24/2012EP2514763A1 Egf receptor epitope peptides and uses thereof
10/24/2012EP2514758A1 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
10/24/2012EP2513310A2 Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1
10/24/2012EP2512512A1 Uniform field magnetization and targeting of therapeutic formulations
10/24/2012CN1980683B Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
10/24/2012CN102753574A Novel conjugates and compositions for immunotherapy and antineoplastic treatment
10/24/2012CN102753200A Influenza nucleic acid molecules and vaccines made therefrom
10/24/2012CN102747103A AIDS vaccine of double-deletion replicative vaccinia virus based on A52L gene and B8R gene
10/24/2012CN102747096A Gene search vector, random gene mutation control method and application thereof
10/24/2012CN102747092A Recombinant defective adenoviruses expressing O type foot and mouth disease virus empty capsid, and applications thereof
10/24/2012CN102747083A Application of splicing factor oncoprotein SF2/ASF in preparation of medicines used for treating leukemia
10/24/2012CN102747046A Construction method and application of oncolytic adenovirus targeting CD123 positive leukemia cell
10/24/2012CN102746387A DNA (Deoxyribose Nucleic Acid) vaccine of HCV (Hepatitis C Virus) and preparation method thereof
10/24/2012CN102746378A Anti-fatty acid synthetase polypeptide and its application
10/24/2012CN102746377A Epitope peptide of mycobacterium trberculosis protein antigen, and its application
10/24/2012CN102743767A Rnai-mediated inhibition of gremlin for treatment of iop-related conditions
10/24/2012CN102743766A Cancer suppressor gene-based anti-liver cancer preparation and preparation process thereof
10/24/2012CN102743765A Application of miR-10a gene in non-small cell lung cancer
10/24/2012CN102743764A Application of RNA interference target sequence of RhoA in preparation of drugs for treatment of glaucoma
10/24/2012CN102743763A Drug for treating glaucoma
10/24/2012CN102743762A Receptor-mediated quantum dot tracing targeted drug delivery system, preparation method thereof and application
10/24/2012CN102145181B siRNA for inhibiting tumor growth and oligomeric nucleic acid combination and application of siRNA
10/24/2012CN101610793B Long lasting drug formulations
10/24/2012CN101469329B Compositions and methods for increasing bone mineralization
10/23/2012US8293719 iRNA agents targeting VEGF
10/23/2012US8293717 Materials and methods for prevention and treatment of RNA viral diseases
10/23/2012US8293700 Anti-bacterial composition especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
10/23/2012US8293463 Dermal micro-organs, methods and apparatuses for producing and using the same
10/23/2012US8293223 Treatment of organ injuries and burns using placental stem cells
10/23/2012CA2584457C Antisense oligonucleotides for treating allergy and neoplastic cell proliferation
10/23/2012CA2567547C Method for enhancing production of isoprenoid compounds
10/23/2012CA2469599C Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
10/23/2012CA2418802C Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
10/23/2012CA2412494C Agonist anti-trk-c monoclonal antibodies
10/23/2012CA2384978C Udp-n-acetylglucosamine: galactose-.beta.1,3-n-acetylgalactosamine-.alpha.-r/(glcnac to galnac) .beta.1,6-n-acetylglucosaminyltransferase, c2gnt3
10/23/2012CA2361009C Her-2/neu fusion proteins
10/23/2012CA2359840C Glycosylated leptin compositions and related methods
10/23/2012CA2257839C Gamma-heregulin
10/18/2012WO2012142476A2 Methods and compositions for the treatment of marfan syndrome and associated disorders
10/18/2012WO2012142434A2 Aav mediated ctla-4 gene transfer to treat sjogren's syndrome
10/18/2012WO2012142083A2 C1q/tnf-related protein 12 and compositions and methods of using same
10/18/2012WO2012141674A2 Compositions and methods relating to argininosuccinate synthetase
10/18/2012WO2012141280A1 Dna vaccine
10/18/2012WO2012139469A1 Delivery system and preparation of low-interference rna drug
10/18/2012WO2012139254A1 Method of selectively driving gene expression in anaerobic tissue by alcohol dehydrogenase promoter and uses thereof
10/18/2012WO2012122334A3 Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
10/18/2012WO2012106702A3 Treatment of leukemia
10/18/2012WO2012103163A3 Compositions and methods for treating cancer while preventing or reducing cardiotoxicity and/or cardiomyopathy
10/18/2012WO2012099375A3 P47phox or p67phox-targeting therapeutic agent for stress disorders, and method for screening for same
10/18/2012WO2012094511A3 Compositions and methods for the treatment of orthopedic disease or injury
10/18/2012WO2011131360A3 Method of determining the metastatic potential of a tumor
10/18/2012US20120264816 Sulfated Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Proliferation
10/18/2012US20120264814 Isolation, Cloning, Sequencing and Functional analysis of ss-casein promoter along with the regions of exon1, intron1 and exon2 using mammary gland derived cell line of Buffalo (Bubulus bubalis)
10/18/2012US20120264625 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
10/18/2012US20120264141 Tuberculosis diagnostic test
10/18/2012US20120263748 Superior Molecular Vaccine Linking the Translocation Domain of a Bacterial Toxin to an Antigen
10/18/2012US20120263747 Albumin-Fused Anti-Angiogenesis Peptides
10/18/2012US20120263702 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis
10/18/2012US20120263682 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
10/18/2012US20120263679 Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof
10/17/2012EP2511294A2 Conjugates and compositions for immunotherapy and anti-tumor treatment
10/17/2012EP2511260A1 Aromatic compound, modification carrier that uses same and is used for synthesizing an oligonucleotide derivative, oligonucleotide derivative, and oligonucleotide construct
10/17/2012EP2510934A1 Methods for promoting neurite outgrowth and survival of dopaminergic neurons
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 870